Who Gets to Accredit Podiatry?

If you're a student or resident, you've probably heard the letters ACGME thrown around in a hallway argument — usually with strong feelings attached and not much detail. The short version: a real proposal surfaced to move podiatric residency accreditation out from under the CPME and into the ACGME, the accreditor for allopathic and osteopathic residencies. It's one of the most consequential identity questions the profession has faced in years, and right now it is unresolved. What follows is the honest-broker version: what's being asked, who wants what, and why reasonable people land on opposite sides.

What's actually on the table

Every residency answers to an accreditor — the body that writes the standards, evaluates programs, and certifies that your training meets the bar. Accreditation is not the same as your license. Your license comes from passing the APMLE and clearing your state board; accreditation is the seal on the program itself.

Today, podiatric residencies are accredited by the Council on Podiatric Medical Education (CPME), an arm of the APMA. MD and DO residencies are accredited by the Accreditation Council for Graduate Medical Education (ACGME) — the same body that defines competencies and program requirements across nearly all of allopathic and osteopathic graduate medical education.

The question: should podiatric residency accreditation move from CPME to ACGME? The trigger was an opening — ACGME signaled it would explore accrediting podiatry as a specialty of medicine if the profession showed interest. One structural fact frames everything that follows: under APMA's bylaws, only the House of Delegates can make a change of this magnitude. No single board, committee, or organization can flip the switch alone.

The case for: parity

Strip the proposal down and the argument for it is a single word: parity. Proponents argue that ACGME accreditation would formally make podiatry a specialty of medicine — training measured against the identical yardstick applied to every MD and DO program in the country.

The downstream claims follow from that. Hospitals, credentialing committees, and payers would read podiatric training as equivalent rather than "different." It could open the door to podiatric residencies inside more academic medical centers and other ACGME-accredited institutions. And it would be much harder for anyone to wave away podiatric education as a lesser pathway. The American Board of Podiatric Medicine's board has publicly backed at least exploring the process, framing it as a step toward parity with allopathic and osteopathic colleagues. For a profession that has spent decades fighting for recognition, "judged by the same standard as everyone else" is a powerful pitch.

Strip the proposal down, and the argument for it is a single word: parity.

The case against: autonomy

The opposing case is also a single word: autonomy. Critics warn that moving accreditation to ACGME would mean relinquishing podiatry's independent oversight to an organization roughly sixty-five times its size — and that a profession this small risks becoming invisible inside a system that large.

The concrete worries are specific. A constellation of profession-specific functions — CPME's accreditation work, the AACPM-run residency match, ABFAS and ABPM curricular involvement, on-site evaluations, and case logging — could be absorbed into ACGME's machinery, weakening podiatry's ability to organize training around its own needs. Several stakeholders have flagged a subtler risk: handing ACGME detailed surgical case-log and volume data could expose how podiatric scope compares to orthopedics, and that data could be used to limit privileging or argue against podiatric programs. And there is no guarantee the trade pays off — nothing in the conversations so far promised that accreditation would actually deliver parity. CPME's own position is cautious: before any engagement with ACGME, run a multi-year, data-driven feasibility study with full stakeholder input.

The number both sides argue about

The single most-cited statistic in this debate is also the most double-edged. ACGME accredits 5,866 programs with 40,041 first-year positions; CPME accredits 222 programs with 609. Inside ACGME, podiatry would represent roughly 1.5% of the system.

That one fact is a Rorschach test. To a proponent, it reads as finally in the big leagues — a seat at the table that defines American graduate medical education. To a skeptic, it reads as a rounding error — a tiny constituency whose specific needs get drowned out by the other 98.5%. Same number, opposite conclusions. That gap is the whole fight.

Where it actually stands

Here is the part that gets distorted in hallway arguments. In September 2025, after gathering feedback from across the profession, the APMA Board of Trustees voted not to participate further in ACGME's exploratory process — citing widespread uncertainty and apprehension, concerns about autonomy and impact on programs and graduates, competing strategic priorities, and the absence of any guarantee that the path leads to parity. Crucially, the board's stated reasoning was that a decision this big, without clear consensus, belongs to the House of Delegates rather than the board.

In response, ACGME paused its podiatry task force, and has signaled it will not move forward without APMA's cooperation. So the accurate status is tabled, not settled: the profession has not committed to pursuing ACGME accreditation, and it has not closed the door either. The question now sits where APMA's bylaws say it must — with the House of Delegates. Poorly-informed SDN gripers claim everyone even remotely involved with the APMA have completely halted this process. This is simply not true. It has been elevated towards a higher decision-making body. In March of 2026 the HOD passed a resolution enabling tabling of "Issues of Magnitude". Then the ACGME debate was tabled as an "issue of magnitude". Appropriately so! Since then the BOT has been on an investigative data-collecting mission so HOD can make an informed decision in this debate. Unfortunately that takes a lot of time, and IMO there hasn't been transparent communication yet about what's happening behind closed doors. This debate is FAR from over.

Why this should matter to you

It is tempting to file this under "politics for the people in suits." Don't. Accreditation is the scaffolding under your training: it shapes how rigorously your program is evaluated, how hospitals and the public interpret the letters after your name, and — eventually — how you are privileged to practice. A change here would touch the daily reality of residency and the long arc of a career.

The other reason to care is about how you carry yourself professionally. This is a genuine disagreement among informed, well-intentioned people who want the same thing — a stronger profession — and disagree about how to get there. The move, as a student or resident, is not to adopt the loudest opinion in the room. It is to understand the actual arguments well enough to hold your own.

The bottom line

Parity is not conferred by a logo. It is earned in clinics, in operating rooms, and in legislatures — and an accreditor's stamp reflects that standing more than it grants it. Whether routing podiatric residencies through ACGME would accelerate that recognition or quietly erode the profession's control over its own training is exactly the question the House of Delegates now has to weigh. Worth following closely. Worth understanding before you form an opinion about it.

— Peter